Drug intelligence / Profile preview

Rhealba Oat plantlets

Development stage
Unknown
Lead developer
Pierre Fabre Dermo-Cosmétique
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Rhealba Oat plantlets extract is a proprietary botanical extract derived from the young shoots (plantlets) of a specific variety of *Avena sativa* (oat), developed by Pierre Fabre (A-Derma). Unlike mature oat grains, the plantlets are harvested at a specific stage of growth to maximize the concentration of active molecules, such as flavonoids and saponins, while being free of detectable proteins to minimize allergic risk. It is primarily used in dermo-cosmetic formulations for its anti-inflammatory, soothing, and skin-repairing properties. It is often formulated into sprays or creams to treat cutaneous pain, irritation, and to promote wound healing following dermatological procedures or minor injuries.

Brand names
A-DermaCutalganEpitheliale A.H
Other names
Rhealba oat extractAvena sativa plantlet extract
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ITK (Interleukin 2-inducible T-cell kinase)Bacterial adhesion processes of Cutibacterium acnes to skin

Beyond the preview

Go deeper on Rhealba Oat plantlets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rhealba Oat plantlets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call